Brind.
  1. Citi initiated positive catalyst watch on Haemonetics and GE Healthcare in the MedTech sector.

Financial analysts, including Needham & Company, Mizuho Financial Group, and Marie Thibault, questioned Haemonetics' long-term growth and product performance.

1 report, 0 independent Updated Jun 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Financial analysts, including Needham & Company, Mizuho Financial Group, and Marie Thibault, questioned Haemonetics' long-term growth and product performance.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Unknown outlet